IL311773A - Peptide - Google Patents

Peptide

Info

Publication number
IL311773A
IL311773A IL311773A IL31177324A IL311773A IL 311773 A IL311773 A IL 311773A IL 311773 A IL311773 A IL 311773A IL 31177324 A IL31177324 A IL 31177324A IL 311773 A IL311773 A IL 311773A
Authority
IL
Israel
Prior art keywords
peptide
Prior art date
Application number
IL311773A
Other languages
English (en)
Hebrew (he)
Inventor
Masahiko Kinebuchi
Yoshinori Suzuki
Original Assignee
Peptidream Inc
Masahiko Kinebuchi
Yoshinori Suzuki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptidream Inc, Masahiko Kinebuchi, Yoshinori Suzuki filed Critical Peptidream Inc
Publication of IL311773A publication Critical patent/IL311773A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL311773A 2021-09-30 2022-09-30 Peptide IL311773A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021161353 2021-09-30
PCT/JP2022/036850 WO2023054712A1 (ja) 2021-09-30 2022-09-30 ペプチド

Publications (1)

Publication Number Publication Date
IL311773A true IL311773A (en) 2024-05-01

Family

ID=85780814

Family Applications (1)

Application Number Title Priority Date Filing Date
IL311773A IL311773A (en) 2021-09-30 2022-09-30 Peptide

Country Status (10)

Country Link
US (1) US20250034212A1 (https=)
EP (1) EP4410816A4 (https=)
JP (1) JPWO2023054712A1 (https=)
KR (1) KR20240082377A (https=)
CN (1) CN118103387A (https=)
AU (1) AU2022355276A1 (https=)
CA (1) CA3234324A1 (https=)
IL (1) IL311773A (https=)
TW (1) TW202334179A (https=)
WO (1) WO2023054712A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025070720A1 (ja) * 2023-09-29 2025-04-03 ペプチドリーム株式会社 ペプチド
TW202535907A (zh) * 2023-11-10 2025-09-16 日商肽夢想股份有限公司 胜肽、胜肽複合體、醫藥組成物、細胞培養用組成物、以及用於醫療用、診斷用或是研究用之組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240912A (en) * 1983-05-09 1993-08-31 Todaro George J Transforming growth factor (TGF) peptides
US5525491A (en) 1991-02-27 1996-06-11 Creative Biomolecules, Inc. Serine-rich peptide linkers
WO2001066140A1 (en) 2000-03-09 2001-09-13 Genzyme Corporation Use of tgf-beta antagonists to treat or to prevent loss of renal function
BR0116024A (pt) 2000-12-07 2005-12-13 Lilly Co Eli Proteìna de fusão heteróloga e uso da mesma
EP1534737A4 (en) * 2002-04-29 2007-10-31 Univ Saint Louis PEPTIDANTAGONISTS OF MEMBERS OF THE TGF BETA FAMILY AND THEIR THERAPEUTIC APPLICATION
US8188260B2 (en) 2005-12-06 2012-05-29 The University Of Tokyo Versatile acylation catalytic RNAs and uses thereof
MY165160A (en) 2010-09-01 2018-02-28 Genzyme Corp TREATMENT OF MYOCARDIAL INFARCTION USING TGF-ß ANTAGONISTS
HRP20201384T1 (hr) 2014-01-01 2020-11-27 Medivation Technologies Llc Spojevi i postupci njihove upotrebe
US10882894B2 (en) * 2015-08-11 2021-01-05 Anie Philip Peptidic TGF-beta antagonists
JP6952747B2 (ja) 2018-09-18 2021-10-20 ファイザー・インク がん処置のためのＴＧＦβ阻害剤およびＣＤＫ阻害剤の組合せ

Also Published As

Publication number Publication date
EP4410816A1 (en) 2024-08-07
CN118103387A (zh) 2024-05-28
EP4410816A4 (en) 2025-11-19
US20250034212A1 (en) 2025-01-30
WO2023054712A1 (ja) 2023-04-06
JPWO2023054712A1 (https=) 2023-04-06
KR20240082377A (ko) 2024-06-10
AU2022355276A1 (en) 2024-05-16
CA3234324A1 (en) 2023-04-06
TW202334179A (zh) 2023-09-01

Similar Documents

Publication Publication Date Title
EP4225364A4 (en) Prefusion-stabilized hmpv f proteins
EP4186256C0 (en) INTER-AGENCY COMMUNICATION VIA AN AD-HOC NETWORK SLICE
EP3802852A4 (en) MANIPULATED CYCLIC PEPTIDES
EP4137404A4 (en) Multicopter
EP4222352A4 (en) BOLTER
EP4107782A4 (en) MICROARRAYS
EP4223314A4 (en) LIPID NANOPARTICLE
EP4217273C0 (en) Rotorcraft
EP4028409A4 (en) NEW PEPTIDES
DK3840767T3 (da) Peptider
EP3957265A4 (en) MICROSCOPE COVER
EP4257597A4 (en) LACTAM-MODIFIED POLYPEPTIDE COMPOUNDS
EP4063561C0 (en) REFINER SEGMENT
EP4163277C0 (en) NEW PYRAZOLE DERIVATIVES
IL289460A (en) Modified bcl9 mimetic peptides
IL311773A (en) Peptide
EP4192823C0 (en) TRIAZOLES DIFLUOROMETHYL-PYRIDIN-2-YL
IL314723A (en) Novel peptides
IL311448A (en) Polypeptide
IL312470A (en) Novel proteins
EP4137505A4 (en) SELF-ASSEMBLING PEPTIDE
EP4154884A4 (en) Anti-sars-cov-2 durg
EP4406961A4 (en) PEPTIDE
EP3914606A4 (en) CYCLIC PEPTIDE
EP4137402A4 (en) MULTICOPTER